Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris

ClinicalTrials.gov ID: NCT02865005

Public ClinicalTrials.gov record NCT02865005. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris

Study identification

NCT ID
NCT02865005
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Seegpharm S.A.
Industry
Enrollment
2,361 participants

Conditions and interventions

Conditions

Interventions

  • Dapsone 5.0% Gel (SEEGPharm) Drug
  • Placebo Other
  • Dapsone 5.0% Gel (Allergan) Drug

Drug · Other

Eligibility (public fields only)

Age range
12 Years to 40 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2016
Primary completion
Oct 31, 2016
Completion
Nov 30, 2016
Last update posted
Dec 19, 2016

2016

United States locations

U.S. sites
35
U.S. states
14
U.S. cities
32
Facility City State ZIP Site status
Catawba Clinical Research Encino California 91436
Catawba Clinical Research Fullerton California 92835
Catawba Clinical Research La Mesa California 91942
Catawba Clinical Research Los Angeles California 90017
Catawba Clinical Research Los Angeles California 90036
Catawba Clinical Research Sherman Oaks California 91403
Catawba Clinical Research Temecula California 92592
Catawba Clinical Research Boca Raton Florida 33486
Catawba Clinical Research Brandon Florida 33511
Catawba Clinical Research Hialeah Florida 33016
Catawba Clinical Research Miami Florida 33175
Catawba Clinical Research Miramar Florida 33027
Catawba Clinical Research South Tampa Florida 33609
Catawba Clinical Research Tampa Florida 33618
Catawba Clinical Research Savannah Georgia 31406
Catawba Clinical Research New Orleans Louisiana 70130
Catawba Clinical Research Norfolk Nebraska 68701
Catawba Clinical Research Omaha Nebraska 68134
Catawba Clinical Research Las Vegas Nevada 89106
Catawba Clinical Research Las Vegas Nevada 89109
Catawba Clinical Research Las Vegas Nevada 89119
Catawba Clinical Research Endwell New York 13760
Catawba Clinical Research New York New York 10012
Catawba Clinical Research High Point North Carolina 27262
Catawba Clinical Research Wilmington North Carolina 28405
Catawba Clinical Research Cincinnati Ohio 45246
Catawba Clinical Research Jenkintown Pennsylvania 19046
Catawba Clinical Research Upper Saint Clair Pennsylvania 15241
Catawba Clinical Research Warminster Pennsylvania 18974
Catawba Clinical Research Nashville Tennessee 37215
Catawba Clinical Research Austin Texas 78746
Catawba Clinical Research El Paso Texas 79902
Catawba Clinical Research Mesquite Texas 75149
Catawba Clinical Research Norfolk Virginia 23507
Catawba Clinical Research Richland Washington 97030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02865005, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 19, 2016 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02865005 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →